Analysis of the assortment of drugs used in Parkinson's disease in the pharmaceutical market of the republic of Uzbekistan

In the Republic of Uzbekistan, special attention is paid to modern approaches to the treatment of Parkinson's disease and the prospects of new drugs. Given the advances in Parkinson's disease research and the emergence of new drugs, it is important to conduct an analysis of the range of drugs used in Parkinson's disease. Assortment analysis of the pharmaceutical market is aimed at studying the offer of drugs used in the treatment of Parkinson's disease. This article analyzes the assortment of drugs used in the treatment of Parkinson's disease registered in the years 2013-2023 of the State Register of drugs, medical products and medical equipment authorized for use in medical practice in the Republic of Uzbekistan [1,2,3]. The results of the assortment analysis are presented in the context of patient needs and quality requirements, which can be useful for manufacturers, distributors and researchers in the pharmaceutical industry.